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Culture-grown astrocytes derived from 3-day-old rat brain were incubated in the 
presence of [3H]guanosine and of the convulsant agent L-methionine-dl-sulfoxi- 
mine (MSO). The resulting [3 H]tRNA was purified from control and MSO-exposed 
cells at several time points during the incubation and was hydrolyzed to 
[3H]guanine and four [3H]methyl guanines which were separated by high pressure 
liquid chromatography. Three of the four [3H]methyl guanines were more highly 
labeled in the [3H]tRNA of the MSO-exposed ceils, relative to that of the control 
cells throughout the entire incubation period. The findings extend to cultured 
astrocytes, the stimulatory effect of MSO on the methylation of neural tRNA 
guanines, previously observed both in vitro using [~4C]S-adenosyl-L-methionine 
and in vivo using [methyl-3H]L-methionine. 
I N T R O D U C T I O N  
It  is g e n e r a l l y  r e c o g n i z e d  tha t  in n o n - n e u r a l  cel ls  p o s t - t r a n s c r i p t i o n a l  m o d -  
i f i ca t ions  o f  t R N A  s t ruc tu r e  c o n t r i b u t e  in a la rge ,  bu t  as  y e t  i n c o m p l e t e l y  
u n d e r s t o o d ,  m e a s u r e  to  m a k e  p r o t e i n  syn thes i s  ce l l - spec i f i c .  S ince  the  
p r o c e s s i n g  o f  c e r e b r a l  t R N A  r e m a i n s  ac t i ve  t h r o u g h o u t  the  f irst  m o n t h  
o f  p o s t n a t a l  d e v e l o p m e n t  (1 -5 )  and  s ince ,  as  we  have  r e c e n t l y  shown ,  
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cerebral tRNA-modifying reactions are affected in vivo and their pattern 
of specificity altered by the convulsant agent L-methionine-d/-sulfoximine 
(MSO) (6), it appeared of interest to examine effects of MSO on the 
biosynthesis of neural tRNA. We chose to study this (7) in culture-grown 
astroglial cells (astrocytes) derived from the 3-day-old rat cerebral cortex 
(8), primarily because there is substantial cytological evidence that MSO 
affects the glial compartment of brain more significantly than the neuronal 
one (9, 10), and also because glutamine synthetase, an enzyme activity 
strongly inhibited by MSO in brain tissue (11), is now known to be an 
exclusively glial protein (12). 
EXPERIMENTAL PROCEDURE 
Astrocyte Culture. The culture procedure was as described previously (8), the cells being 
grown in plates 75 cm 2 containing 10 ml of growth medium (7). Briefly, forebrains of 3 to 
4-day-old rats were dissected under sterile conditions, minced, and trypsinized in 0,25% 
trypsin in Earle's balanced salt solution (BSS). The suspension was centrifuged, and the 
pellet was washed once in BSS, and diluted to yield 10 plates per forebrain. Cells were 
grown in a medium composed of 10% fetal bovine serum in minimum essential medium, 
with either Earle's or Hanks'  BSS. The medium was supplemented with 100 units penicillin, 
100 ~g streptomycin, and 100 units polymyxin per ml medium. Cells were grown in a 
National incubator, in an atmosphere of 95% air and 5% CO2. The medium was changed 
on days 4, 8, and 11, and the cells harvested by days 17-19. 
Exposure of  Astrocytes to [3H]Guanosine and MSO. At specified intervals (see Results) 
preceding the harvesting of the cells, the growth medium received 62.5 ~Ci of [3H]guanosine 
(14.5 Ci/mM). Half the plates also received 10 mg of MSO/plate 2 hr before they were 
harvested and their RNA extracted. Under these conditions, the cells appeared unchanged 
and no evidence of toxicity was noted on inspection. A systematic study of the effect of 
MSO on cell viability was not intended in this study, 
tRNA Extraction. The extraction procedure has been described in detail previously (7). 
Briefly, the medium was decanted and the cells rinsed with phosphate-buffered saline con- 
taining, in g/liter: CaCI2 and MgCIz, 0.1; KCI and KHzPO4, 0.2, NaC1, 8; and NazHPO4, 
215. Equal volumes of TNE buffer (0.01 M Tris HCI, pH 7.8, 0.1 M NaCI, 0.01 M Na 
EDTA) in diethylpyrocarbonate-treated water containing 10 mM MgClz and [~-mercapto- 
ethanol, pH 8.2, were mixed with TNE-saturated phenol and used to transfer the cells into 
test tubes to which were added 5 ml of CHCI3 followed by vigorous agitation and incubation, 
with shaking, at 60~ for 40 rain. Three volumes of 95% ethanol were added to the aqueous 
phase resulting from a 9000 g, 15-rain centrifugation of the above suspension, and the RNA 
was allowed to collect overnight at -20~ 
Hydrolysis of  tRNA and Separation of its Guanine and Methyl Guanines. A tRNA fraction 
was obtained following suspension of the centrifuged RNA pellet in 0.01 M Tris HCI, 
containing 0.01 M MgC12, 0.001 M EDTA, and 0.05 M NaC1, pH 7.5 (buffer A), and chro- 
matography on DEAE-cellulose (13). The tRNA fraction was eluted with 0.7 M NaCI. 
Following dialysis to remove NaCI and lyophilization, the tRNA was hydrolyzed according 
to Klagsbrun (14). Separation of the guanine from l-methyl-, 7-methyl-, NZ-methyl, and 
NZ-dimethyl guanine was accomplished using HPLC (7, 15). 
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tRNA Aminoacylation. The rat liver or brain aminoacyl-tRNA synthetases were prepared 
as described (7). Aminoacylation of astrocyte tRNA was carried out in a reaction volume 
of I ml containing, in order of addition: 1 ~Ci [3H]lysine or phenylalanine; 0.4 M Tris HCI, 
pH 7.5; 20 mM (for lysine) or 50 mM (for phenylalanine) KC1; 10 mM (for lysine) or 20 mM 
(for phenylalanine) MgClz; 1 mM (for lysine) or 4 mM (for phenylalanine) ATP; 0.6 mM 
CTP; 2 mM 13-mercaptoethanol; 0.3-0.5 A26o units of tRNA; and 0.4-0.8 mg of amino- 
acyl-tRNA synthetase protein. Incubation was for l0 min at 37~ The procedure of Yang 
and Novelli (16) was used to isolate and quantitate the [3H]aminoacyl-tRNA. 
RESULTS 
RNA Yield and tRNA Aminoacylation. Growing astrocytes for 17 days 
yielded 1.4-1.5 A26 o units per culture dish. The aminoacylating capacity 
of the tRNA extracted from ten control and ten MSO-exposed dishes is 
compared in Table I. Lysine acceptance was between 60- and 100-fold 
higher than phenylalanine acceptance when the hepatic tRNA-aminoacyl 
synthetase was used; acceptance values were lower when the 
tRNA-aminoacyl synthetase preparation was derived from brain tissue. 
Incorporation o f  [3H]Guanosine into Astroglial RNA and tRNA. The 
labeling of total RNA as a function of the exposure time (1-8 hr) to 
[3H]guanosine and to MSO (2 hr) is shown in Figure 1, while Figure 2 
depicts the specific radioactivity (sra) of the [3H]tRNA fraction. Figure 
1 indicates a negligible amount of total RNA labeling during the initial 
3-3.5 hr, while Figure 2 illustrates a gradual increase in the sra of 
[3H]tRNA between 2.5 and 3 hr, followed by a steep labeling spurt in 
both control and MSO-exposed cells between 3 and 4 hr. The figures also 
show a uniformly higher incorporation into total RNA in control cells and 
higher than control [3H]tRNA sra values in the MSO-exposed cells during 
the second half of the [3H]guanosine incorporation process. 
Effect o f  MSO on Incorporation of  [3H]Guanosine into Guanine and 
Methyl Guanine Residues of  Glial tRNA. Following hydrolysis of 
[3H]tRNA at each time period indicated in Figure 2, its [3H]guanine 
residues were separated from its [3H]methyl guanine residues by HPLC 
(15). Figure 3 illustrates the distribution of the radioactivity at the two 
early time points among four individual [3H]methyl guanines and in their 
sum ( ~  raG). Initially, [3H]methyl guanines represented a much higher 
proportion of the [3H]tRNA formed in the MSO-treated than in the control 
cells, relative to [3H]guanine. This "hypermethylating" effect of MSO 
was particularly evident at the level of the two N-methylated guanines, 
which accounted for 10% of the total radioactivity in the MSO-treated, 
as against 1.6% in the control, cells at 1.5-1.75 hours. Conversely, at the 
same time, [3H]l-methyl guanine represented 2.9 and 0.6% of the 
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[3H]tRNA formed in the control and the MSO-exposed cells, respectively. 
These findings thus reveal not only marked differences in the early la- 
beling pattern of the individual [3H]tRNA methyl guanines between con- 
trol and MSO-treated astrocytes, but they also confirm the previously 
described ability of this agent to alter the specificity of neural tRNA 
methyltransferases (6, 17). 
By 8 hr of incubation all four tRNA guanine residues were affected by 
MSO (Table II). Particularly striking in this respect was the more than 
twofold increase over control values in 1-methyl guanine and N~Z-dimethyl 
guanine radiactivity. 
DISCUSSION 
The exposure of the astrocytes to [3H]guanosine and, in the case of the 
experimental group of cells, to 1 mg/ml MSO for 2 hr as well, resulted 
in the labeling profile for total cellular RNA shown in Figure 1. Several 
reasons may account for the observed temporal delay (3-3.5 hr) in RNA 
labeling, most of which can only be speculated upon, since very little is 
known about glial transport, metabolism, and the tRNA precursor prop- 
erties of guanosine. It is known, however, that brain has an active system 
of enzymes involved in nucleoside interconversions and phosphorylation 
(18) and that it is rich in a guanosine-inosine-specific phosphorylase (19, 
20) which is distinct from the nucleoside phosphorylase utilizing adeno- 
sine. It is not known whether in neural cells, as is likely to be the case 
in Novikoff hepatoma cells (21), this enzyme exists in more than one 
T A B L E  I 
AMINOACYLATION OF ASTROGLIAL t R N A  BY LIVER AND BRAIN t R N A  
AMINOACYLTRANS FERAS ES 
Liver enzyme ~ Brain enzyme ~ 
Amino acid Control tRNA b MSO tRNA b Control tRNA b MSO tRNA b 
Lysine 12.9 16.8 8.4 11.5 
Phenylalanine 0.21 0.18 0.06 0.05 
Values (averages of two separate experiments) are in pmol/A26dmg protein. Liver and 
brain enzyme refer to tRNA aminoacyltransferase preparations partially purified (7) from 
adult rat liver and brain. 
b Control and MSO tRNA refer to tRNA isolated, respectively, from normal astrocytes and 
from astrocytes exposed for 2 hr to 1 mg/liter of MSO. 
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Fro, 1. The incorporation of [~H]guanosine into astrocyte ribonucleic acids, Astrocytes 
grown for 17 days were incubated in the presence of [3HJgaanosine and MS9 as described 
in Experimental Procedure. At the times indicated and for the most part with half-hour 
displacements between the control and the MSO-exposed cells (for reasons of ease of 
manipulation), the cells of 10 plates were subjected to RNA extraction and the determination 
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FIe. 2. The specific radioactivity of [3HJtRNA. The [3H]tRNA fraction was obtained from 
the [3H]RNA depicted in Figure 1 and its radioactivity and A260 content were determined, 
as indicated. 9 = control cells; 9 = cells exposed to MS9 for 2 hr. 
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intracellular location, i.e., in the soluble cell sap and in the plasma mem- 
brane. 
The formation of glial RNA from [3H]guanosine was recently reported 
by Yanagihara (22), who found it to be higher than in neurons and who 
also noted a 6.5-fold higher uptake of [3H]guanosine by bulk-isolated glial 
cells, relative to neuronal perikarya. The labeling of astrocytic tRNA 
(Figure 2), recently examined in the 3-day-old rat brain in vivo (7), began 
sluggishly, but from 3 to 3.5 hr onward its specific radioactivity (sra) 
increased by more than threefold in 1 hr. The effect of MSO appeared 
to be biphasic in nature, i.e., [3H]tRNA formation was lower than in 
control cells up to 3.5 hr, becoming higher in the second half of the 
labeling period and reaching 20% higher than control sra values by 8 hr. 
It is not possible at this time to fully assess the reasons for the biphasic 
effect of MSO since it is not possible to correlate its action on the 
[3H]guanosine incorporating process to its inracellular concentration. It 
is likely, however, that MSO entered the astrocytes with no difficulty 
since, using [3H]MSO, we showed its entry into the brain to be relatively 
unencumbered under a number of different experimental conditions (23, 
24). On the cellular level, a glial locale for its early action, i.e., during 
the 3 hr following its administration to rodents, has been suggested. We 
showed an apparent concentration of [3H]MSO in bulk-isolated astrocytes 
during the first hour following its intrathecal administration to 18-day-old 
rats (25), while, more recently, Phelps (9) reported an accumulation of 
glycogen in astrocytes following MSO, a finding further explored by Betel 
et al. (26) and Hevor and Gayet (27). 
The early effects of MSO on the methylation of the four individual 
tRNA guanines were of three different sorts: higher than control for N 2- 
methyl and Nz2-dimethyl guanine, lower than control for 1-methyl guanine 
and both higher and lower than control for 7-methyt guanine (Figure 3). 
By 8 hr, however (Table II), the sra of the [3H]tRNA formed in the MSO- 
exposed cells had overtaken the control value by 36%, and the radioac- 
tivity of all [3H]methyl guanines was higher by an average of 102%. These 
results complement our previous findings (6, 17) of an effect of MSO on 
rat brain guanine tRNA methyltransferases. It is of interest that Brunke 
et al. (28) recently reported that the administration of the carcinogen 9,10- 
dimethyl-l,2-benzanthracene specifically stimulates the N2-guanine tRNA 
methyltransferase of rat mammary gland tumors, while Glazer and Hart- 
man (30) reported this enzyme to be the primary target of 5-azacytidine 
and dihydro-5-azacytidine action in murine leukemia L1210 cells. Whether 
glial NZ-guanine tRNA methyltransferase is a primary target of MSO 
action awaits elucidation. 
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